Tacrolimus Capsule
Product Images NDC 65897-0010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 65897-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (05mg Blister Carton)

This is a description of Tacrolimus Capsules, USP containing 100 capsules, each capsule containing Tacrolimus USP 0.5mg. It includes information on inactive ingredients and usual dosage recommendations. The capsules are not filled to maximum capacity and should be stored at a specified temperature range. The product is manufactured by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. from China.*

FDA Label Image

Image Description (1mg Blister Carton)

This is a description of Tacrolimus Capsules, USP. Each capsule contains Tacrolimus USP 1mg and inactive ingredients such as anhydrous lactose, hypromellose, magnesium stearate, and croscarmellose sodium in a hard gelatin capsule. The usual dosage information can be found in the package insert. It is recommended to store the capsules at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The capsules are not filled to maximum capacity. The product is manufactured by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. in China.*

FDA Label Image

Image Description (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.